Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
Clinical trial NCT01568580 · COMPLETED
Trial details
- NCT number
- NCT01568580
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2006-09-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.